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A B S T R A C T
In this research, we measured the activity of paraoxonase (basal and activated) en-
zyme, and components of lipid status components (total cholesterol, LDL cholesterol,
HDL cholesterol and Apo A I) in the serum of patients, undergoing bypass surgery. We
also tested how the applied EKC affected changes of defined indicators. Measuring of
all the given parameters was conducted prior to the operation, 90 minutes, 1.5 hour, 6
hours, 24 hours and 72 hours, on 29 patients (11 of them did undergo myocardium
revascularization with the application of EKC, while the rest of them did not). Activity
of paraoxonase (both basal and activated) changes significantly during the postopera-
tive period, in relation to pre-operative values, p < 0.05. Total cholesterol concentration
is reduced in both examined groups, regardless of the application of EKC. This trend is
also accompanied by LDL cholesterol concentration. On the other hand, HDL choles-
terol concentration during post-operative period does not indicate any significant statis-
tical change in relation to pre-operative values, while we noticed difference with regard
to EKC application, 90 minutes after surgery. This change of lipid status indicator is
partly due to heparin, a stimulator of lipoprotein lipase that was applied during the
surgery. Our conclusion is that lipid profile changes significantly after the bypass sur-
gery, mostly regardless of the application of EKC.
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Introduction
Paraoxonase, aryldialkylphosphatase
is a serum esterase, synthetized in liver.
It is a catalyzor for hydrolysis of orga-
nic-phosphoric compounds, like paraoxon,
for example. It is capable of hydrolyzing
esters of phosphatic and phosphitic acid,
as well as esters of aromatic carboxyl ac-
ids. When it comes to its structure, hu-
man serum paraoxonase is a richly gly-
cosylated protein, molecular mass of 45
kDa. It is bonded by its N-thermal hydro-
phobic domain to Apo A I apolipoprotein
HDL particles, a high-density lipoprotein.
Determining paraoxonose activity can be
useful for discovering resistance to ath-
erosclerosis development. Namely, it has
been discovered that paraoxonase takes
part in the inhibition of low-density lipo-
protein particles’ oxidation; therefore, it
is considered to be the independent factor
of protection against atherogenesis; that
is why most of information given in the
literature relate the changes in the activ-
ity of this enzyme with cardiac disor-
ders1–3.
Changes in the paraoxonase activity,
conditioned by the surgery, were mea-
sured after kidney transplantation4.
Our examining encompassed 29 pa-
tients, who have undergone bypass sur-
gery. Only 18 of them did not undergo
revascularization of myocardium, support-
ed by extracorporal circulatory system,
while the rest of them did.
Apart from paraoxonase activity (both
activated and inactivated), we also deter-
mined lipid status indicators in the se-
rum of these patients: LDL cholesterol,
HDL cholesterol and Apo A I.
We were interested in how the values
of given indicators vary the first few days
after the surgery, and whether or not we
can conclude that the intensity and direc-
tion of the changes depends on the use of
extracorporal circulation.
Patients and Methods
Upon obtaining Hospital Ethics Com-
mittee approval and informed consent
from patients, 29 patients undergoing the
operative procedure of aortocoronary by-
pass between November 2001 and Febru-
ary 2002 were enrolled in this prospective
clinical study. Inclusion criteria were tri-
ple coronary disease, age 60–70 years,
and no use of antioxidant medication (allo-
purinol, mannitol, capropril and deferoxa-
mine) or anti-inflammatory drugs (corti-
costeroids, acetylsalicylic acid and its
derivatives). Patients were divided into
two groups: EKC(+); n = 11 on conven-
tional myocardial revascularization with
CPB support, and EKC(–); n = 18 submit-
ted to open heart procedure of myocardial
revascularization without extracorporal
circulation. Exclusion criteria included left
ventricular ejection fraction < 40%, chro-
nic inflammatory disease, diabetes melli-
tus, and previous cardiosurgical procedure.
Anesthesiology technique and
monitoring
All patients received premedication
with morphine (Morphine Merck, Merck
KgaA, Darmstadt, Germany), 10 mg i.m.
one hour preoperatively. The general an-
esthesia protocol was the same for all pa-
tients and included induction with 0.1
mg/kg midazolam (Dormicum, F. Hoff-
man-La Roche Ltd., Basle, Switzerland),
25 g/kg alfetanyl (Rapifen, Janssen
Pharmaceutica, Beerse, Belgium) and 0.5
mg/kg i.v. atracurium (Tracrium, The
Wellcome Foundation Ltd., London, UK).
Upon orotracheal intubation, patients
were connected to mechanical ventilation
(tidal volume of 12 ml/kg and frequency
of 12 inspirations/minute) (Cato, Dräger,
Lübeck, Germany). Anesthesia was main-
tained by a mixture of nitrogen and oxy-
gen (60%:40%) and isoflurane (Forane,
Abbott Laboratories S.A., Abbott Park,
IL, USA) of 1–1.3 minimal alveolar con-
centration.
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Patient monitoring consisted of elec-
trocardiography (ECG), pulse oximetry,
and capnography. Invasive arterial pres-
sure was monitored after radial artery
catheter puncture (Arrow International,
Reading, PA, USA). Using Seldinger tech-
nique and medial approach, a 3-luminal
central venous catheter (Arrow Interna-
tional, Reading, PA, USA) was introduced
through the right internal jugular vein
for the right atrium pressure monitoring.
The pressure curves and numerical val-
ues were monitored on the screen (Hew-
lett Packard Viridia CMS, Hewlett Pac-
kard, Boeblingen, Germany).
Operative technique
Upon access to the heart through me-
dial sternotomy and pericardiectomy fol-
lowing previous graft preparation, extra-
corporal circulation is established by the
aorta and right atrium double-stage can-
nulation. Artificial ventricular fibrillation
is provoked, the aorta is clamped, and
Buckberg cardioplegic solution is injected
into the aortic bulb. During the creation
of anastomosis, retrograde cardioplegia
through the cannula in coronary sinus is
used. Before the creation of proximal ana-
stomoses, warm blood is administered re-
trogradely, and the aortic clamp is re-
leased upon rhythm restitution.
In a procedure without use of the ex-
tracorporal circulation device, access to
the heart is the same, whereby exposure
of the target vessels and stabilization of
the myocardial wall are achieved by use
of Octopuss 3 and Starfish vacuum stabi-
lizers (Medtronic Inc., Minneapolis, MN,
USA). Coronary circulation is ensured by
the placement of an appropriately sized
intracoronary shunt. Distal anastomoses
are created by the continuous suture
technique with Prolen 7–0, and proximal
anastomoses with Prolen 6–0.
Blood samples were taken prior to sur-
gery (1 day before) and after surgery (90
minutes, 6 hours, 24 hours and 72 hours).
The blood was centrifuged for 15 min-
utes/3000 r.p.m. in Heraus Minifuga T.
centrifuge. Serum was stored at –40 °C,
till the analysis.
Paraoxonase assays were performed
in the absence of sodium chloride (basal
activity), and in the presence of 1 mol/L
NaCl (NaCl stimulated activity)5,6. Initial
rates of hydrolysis of paraoxon (O,O-di-
ethyl-O-p-nithrophenylphosphate; Sigma
Chemical Co, London, UK) were deter-
mined by measuring liberated p-nitrophe-
nol at 405 nm at 37 °C on a Tehnicon RA-
1000 autoanalyzer (Bayer, Milan, Italy).
The basal assay mixture included 2.0
mmol/L paraoxon and 2.0 mmol/L of Ca-
chloride in 0.1 mol/L Tris-HCl buffer, pH
8.0. To 350 L the reagent mixture 10  of
serum was added. For the NaCl-stimu-
lated assay, 1 mol/L NaCl was added into
above described mixture. Phenylacetate
was used as a substrate to measure ary-
lesterase activity7. Initial rates of hydro-
lysis were determined spectrophotometri-
cally by detecting the increase in phenol
concentration at 270 nm. The reaction
mixture contained 2.0 mmol/L phenylace-
tate (Sigma) and 2.0 mmol/L Ca-chloride
in 0.1 mol/L Tris-HCl buffer, pH 8.0.
The total cholesterol, LDL and HDL
cholesterol, Apo A I have been measured
on the Olympus AU 2700 analyzer, and
we also used the original putty by the
same manufacturer.
Correction of plasma dilution
Post-operative concentration values of
all measured biochemical indicators in
the serum were corrected according to
McColl et al., the following formula:
corrected concentration = measured
concentration x (l – Htc after surgery)/
(1 – Htc prior to surgery)8.
Statistical analysis
The results obtained (of absolute con-
centration or activity) were processed by
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the standard statistical methods using
statistical program Sigmastat (Version
2.0, Jandel Co.). The nonparametric test,
Mann-Whitney, was used to test differ-
ences of two studied groups. The Fried-
man repeated measures analysis of vari-
ance on ranks was performed to test
differences between preoperative and post-
operative values. The p < 0.05 value is
considered to be statistically significant.
Results
Table 1 shows absolute values of POX
activities (basal activity and NaCl- stim-
ulated activity) and HDL cholesterol ex-
pressed by median and range. By means
of Mann-Whitney test, we compared val-
ues of the given parameters at the same
point of determining group of patients
who did not undergo EKC, and those who
did.
Based on the obtained values, we can
conclude that the measured basal activity
paraoxsonase statistically differ only in
the measuring point 24 hours after sur-
gery, depending on whether the myocar-
dium revascularization was made with or
without extracorporal circulation.
Furthermore, by applying Friedman
repeated measures analysis of variance
on ranks we compared activities of basal
POX at post-operative points, to pre-oper-
ative activity. The results obtained indi-
cate that at all post-operative measuring
points, the basal POX activities statisti-
cally significantly differ, compared to pre-
-operative activities values (p < 0.05).
By using Mann-Whitney test, we have
concluded that activity of NaCl-stimula-
ted POX differs at the measuring point 24
hours after surgery, only in those patients
that have undergone EKC, and those that
have not.
By Friedman repeated measures anal-
ysis of variance on ranks, we have also
compared activities of NaCl-stimulated
post-operative measuring points to pre-
-operative activities. At all points of mea-
suring catalytic concentrations NaCl-sti-
mulated POX after surgery, we have
found statistically significant change, in
relation to pre-operative activity (p < 0.05).
Table 1 shows the result of statistical
significance of differences in HDL choles-
terol concentration at the individual mea-
suring point, between groups of patients
that have undergone EKC, and those that
have not. Considering the fact that statis-
tic significance limit has the value p <
0.05, it is obvious that the concentration
of HDL in the examined groups of pa-
tients differs only at the first post-opera-
tive measuring point, i.e. 1.5 h after sur-
gery. This is, at the same time, the only
measuring point at which HDL choles-
terol concentration values differ, with re-
gard to pre-operative concentration.
Table 2 shows absolute values of the
overall cholesterol concentration, LDL
cholesterol and Apo A I, given in median
and range. By using Mann-Whitney test,
we compared values of the given parame-
ters at the same measuring point, of the
patients that have undergone EKC and
those that have not. The value p < 0.05 is
determined as the border level of signifi-
cance. The statistically significant differ-
ence, related to the application of EKC,
has not been found at none of the measur-
ing points. By Friedman repeated mea-
sures analysis of variance on ranks, we
have compared values of the overall cho-
lesterol concentration after surgery with
those before the surgery. At all post-oper-
ative measuring points the value of the
overall cholesterol concentration statisti-
cally differs significantly from the pre-op-
erative value.
We could say that the trend of the to-
tal cholesterol follows, to some extent,
LDL cholesterol; i.e. at all measuring
points after the surgery, we have discov-
ered (by using Friedman repeated mea-
sures analysis of variance on ranks
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(Dunnett method) statistically significant
difference with regard to pre-operative
LDL concentration.
Using the same method, we have dis-
covered that the measured concentration
of apolipoprotein A I, at all post-operative
points, statistically differs from pre-oper-
ative measuring points.
Discussion
For most of its part, the research, re-
lating lipid status with heart surgery, is a
study-observation of statine therapy fla-
vostatine, lovostatine, paravastatine, pro-
bucole) during longer post-operational
period (weeks, months).It is the mainte-
nance of high concentration of ateropro-
tective HDL and consistent LDL/HDL
concentration ratio, ranging from 2.2–
2.4, that postpones formation of athero-
sclerotic lesions in the transplant seg-
ment9,10.
We were interested in whether the
changes of lipid status components (total
cholesterol, LDL cholesterol, Apo A I) are
visible the first few days after surgery,
and whether the application of extracor-
poral circulation can cause differences in
dynamics changes. It is the application of
cardiac-pulmonary bypass during a heart
surgery, with the blood components being
exposed to non-physiological surface, that
takes part in the activation of comple-
ments, sequestration of leukocytes in
lungs, and the increased volume of lipid
peroxidation11. The development of sys-
tem oxidative stress increases reperfu-
sion of highly oxygenized blood, which is
the result of ishemia.
By measuring paraoxonase activity,
we wanted, to some extent, to support the
obtained results of the parameters given
above, since that enzyme is related to
HDL particle. The authors have pointed
to the lowered POX activity in patients
that have suffered myocardium heart at-
tack, 72 hours after they experienced
chest pain12. Paraoxonase is an enzyme,
susceptible to genetic polymorphism,
which is based on substitution by Arg
aminoacid, at Gln point, at position 55 of
polypeptide chain. Furthermore, the POX
activity depends on the concentration of
calcium ions that is why, in order to de-
fine its activity, we have avoided use of
EDTA, which forms complexes with Ca-
ions (all parameters have been measured
in serum).
There is no literature regarding the
change of POX activity after heart sur-
gery. Activity of that hydrolase was deter-
mined only in patients that have under-
gone kidney transplantation4, and after
laparoscopic colecistoctomy13.
It is the reduced POX/HDL and POX
Apo A I ratio that causes reduction of
antioxidative HDL capacity, which can be
risk factor for atherosclerosis develop-
ment in transplanted patients4.
Significantly reduced concentration of
HDL-cholesterol has been described in
patients after AIM, with the simulta-
neous increase of the overall I LDL cho-
lesterol concentration14.
Most likely, it is the use of heparin
during surgery that is partly responsible
for reduction of LDL cholesterol concen-
tration, which results in reduction of the
overall cholesterol concentration15.
Miida et al. have measured changes in
the overall cholesterol, trigliceride and
apolipoproteine A I, B and E concentra-
tion, in the patients with acute myocar-
dium heart attack, who have undergone
urgent coronary angiography, within the
period of 6 hours after heart attack16.
According to them, the reduction of
cholesterol and trigliceride concentration
is partly due to the use of heparin during
the surgery. Furthermore, in this re-
search the authors have divided patients
into 2 groups: those with the low initial
HDL concentration (with statistically sig-
nificant increase of HDL concentration
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discovered after the surgery), and those,
whose initial HDL amount came within
referent scope, and there was no signifi-
cant increase of concentration after the
surgery. This can be partly explained by
the fact that heparin stimulates the re-
lease of LPL enzyme, a lipoprotein lipase,
which helps the hydrolyze of triglyceride-
rich lipoproteins (VLDL, IDL, LDL). Kek-
ki et al. suggest that it is the activity of
LPL that provides lipid components for
HDL, during the lipolyze of triglyceride-
rich lipoproteins17.
Another state of increased risk from
coronary disease development is familiar
hypercholesterolemy. One of the ways to
treat these patients is HELP (heparin-in-
duced extracorporal lipoprotein precipi-
tation). This method is based on LDL pre-
cipitation with heparin, at low pH, with
the absence of two-valent cations7.
The bypass surgery is closely related
to the use of heparin, which keeps the
blood liquid. This is especially important
for EKC patients, considering that the
contact between the blood and alien sur-
face can activate the coagulation cascade,
by activating Hageman’s factor.
The results of this research have indi-
cated the significant change of the lipid
profile after the bypass surgery, which is
mostly independent of the EKC use.
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AKTIVNOST PARAOKSONAZE I KONCENTRACIJA INDIKATORA
LIPIDNOG STATUSA U SERUMU KARDIOLO[KIH BOLESNIKA
S A @ E T A K
U ovom istra`ivanju mjerena je aktivnost paraoksonaze (bazalne I aktivirane), te
komponenti lipidnoga statusa (ukupni kolesterol, LDL kolesterol, HDL kolesterol i Apo
A I) u serumu bolesnika podvrgnutih ugradnji premosnice. Mjerenja svih parametara
na~injena su prije operacije, 90 minuta, 1.5 sat, 6 sati, 24 sata i 72 sata nakon operacije
kod 29 bolesnika (kod njih 11 je revaskularizacija miokarda tijekom operacije na~inje-
na uz potporu izvantjelesnog krvotoka, a kod ostalih nije kori{tena EKC). Aktivnost
paraoksonaze (bazalne i aktivirane) zna~ajno se mijenja tijekom postoperativnog pe-
rioda u odnosu na predoperativne vrijednosti (p < 0.05). Koncentracija ukupnog ko-
lesterola smanjuje se u obje ispitivane skupine, neovisno o primjeni EKC. Taj trend
prati i koncentracija LDL kolesterola. S druge strane, koncentracija HDL kolesterola
tijekom postoperativnog perioda se ne mijenja zna~ajno u odnosu na predoperativne
vrijednosti tijekom postoperativnog perioda. Navedene promjene pokazatelja lipidnoga
statusa mogu djelomi~no biti uzrokovane primjenom heparina tijekom operacije. On
mo`e stimulirati lipoprotein lipazu. Mo`e se zaklju~iti da se profil lipida zna~ajno
mijenja nakon ugradnje premosnica, uglavnom neovisno o primjeni EKC.
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